Cost of disease-modifying therapies for multiple sclerosis continues to rise in US
Pharmaceutical Technology
MAY 19, 2023
DMTs for MS have a high price tag, particularly in the US. A similar trend of price increases was also seen for MS generics and biosimilars. However, they cannot provide a cure and have a very limited impact on halting disease progression.
Let's personalize your content